Iovance Biotherapeutics appoints Corleen Roche as chief financial officer Iovance Biotherapeutics appoints Corleen Roche as chief financial officer Post ContentiovaRead More You might also be interested in reading DOCEBO Q2 2025 Earnings Preview. July 15, 2025 In Mainstream ← Previous post Next post →